Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

BACKGROUND: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of “clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400232/
https://www.ncbi.nlm.nih.gov/pubmed/30880943
http://dx.doi.org/10.2147/COPD.S196383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400232/
https://www.ncbi.nlm.nih.gov/pubmed/30880943
http://dx.doi.org/10.2147/COPD.S196383

Ejemplares similares